Skip to content
Search

Latest Stories

Health committee’s new report calls for urgent pharmacy workforce plan

The Health Committee’s new report has reminded the government of a much-needed pharmacy workforce plan to support recruitment, training, and retention of staff.

The report makes a number of recommendations to optimise workloads across primary care, reduce pressure on general practice and hospitals, and support the integrated care systems.


It also recognises the potential of pharmacist independent prescribers to support patient care, backed by appropriate supervision, training, and opportunities for professional development.

RPS England gave evidence to MPs on the Committee at a public hearing in May, highlighting key issues to support the pharmacy workforce.

RPS director for England, Ravi Sharma, said: “Today’s report underlines the urgent need for the Government to set out a comprehensive workforce plan for health and care.

“It rightly recognises that boosting recruitment and retention, supporting staff wellbeing, fostering inclusion and diversity, and investing in education and training will be crucial to the future of the NHS.

“Pharmacy teams will play a key role in the NHS recovery, but with continued pressures on staff we need support for the workforce so they can keep looking after patients.

“The next generation of pharmacist independent prescribers will make a huge difference to patient care, but there are some key factors to make the most of their skills.

“I would urge the Government and NHS to listen to the Committee’s call for an integrated and funded workforce plan for pharmacy, which ensures that all pharmacists have adequate access to supervision, training, and protected learning time, along with clear structures for professional development.”

Responding to the report, Malcolm Harrison, CEO of the Company Chemists' Association, called it "yet another reminder that the entire healthcare system is suffering from recruitment and retention challenges - and that community pharmacy is not immune.

"We wholeheartedly support the Committee’s call for a funded and integrated workforce plan – something that the CCA has advocated for some time, and it must be published without delay.

"We also agree the plan must account for the onset of all newly qualified pharmacists eventually becoming independent prescribers. Greater opportunities must also be granted for independent prescribers in community settings, to utilise their newly acquired skills. As the report highlights, pharmacies can only do more if they are able to access the funding and investment they need.

"We also thank the Expert Panel report for highlighting the staffing challenges in community pharmacy and in particular the recruitment of pharmacists from community settings directly into Primary Care Networks.”

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less